Your appetite and metabolism gradually return to their previous patterns after stopping
FDA approval allows doctors to prescribe a medicine after regulators review evidence and decide whether benefits outweigh risks for a specific use
Retatrutide is set to play a major role in advancing metabolic health
Retatrutide , the triple agonist targeting GLP-1, GIP, and glucagon receptors, showed 24+ percent weight loss in phase 2 trials
You have fewer crashes blood sugar swings become less dramatic, and energy feels more steady
Best choices depending on priorities Significant weight loss: Semaglutide or tirzepatide Simple weekly dosing: Trulicity, Ozempic, or Mounjaro Daily pill instead of injections: Rybelsus Long track record of use: Liraglutide options such as Victoza or Saxenda How to Get a GLP-1 Prescription GLP-1 prescriptions can be obtained through a provider visit, telehealth service, or weight management clinic